Significant effect of HLA-DRB1 matching on acute rejection of kidney transplants within 3 months.
Nojima
M
M
Department of Urology, Hyogo College of Medicine, Nishinomiya, Japan.
Ichikawa
Y
Y
Ihara
H
H
Yoshimoto
T
T
Kyo
M
M
Nagano
S
S
Shima
H
H
D000208:Acute Disease; D000328:Adult; D004351:Drug Resistance; D005260:Female; D005838:Genotype; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology; D006146:Guanidines / Q000627:therapeutic use; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology*; D059811:HLA-DRB1 Chains; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D015996:Survival Rate; D013997:Time Factors
D006146:Guanidines; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; C037258:gusperimus